انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
المدونة الصوتية تستحق الاستماع
برعاية
![Advances in Care podcast artwork](https://cdn.player.fm/images/55928701/series/ElP1AC184YuHqdZr/32.jpg 32w, https://cdn.player.fm/images/55928701/series/ElP1AC184YuHqdZr/64.jpg 64w, https://cdn.player.fm/images/55928701/series/ElP1AC184YuHqdZr/128.jpg 128w, https://cdn.player.fm/images/55928701/series/ElP1AC184YuHqdZr/256.jpg 256w, https://cdn.player.fm/images/55928701/series/ElP1AC184YuHqdZr/512.jpg 512w)
![Advances in Care podcast artwork](/static/images/64pixel.png)
1 Advancing Cardiology and Heart Surgery Through a History of Collaboration 20:13
[Extended Release] Defining zero emissions buildings
Manage episode 463765429 series 2941835
Join senior editor Andrea Corona and Nate Bolton, Engineering Design Manager at Genesis EIC, as they discuss the U.S. Department of Energy (DOE) new definition for zero emissions buildings (ZEB), offering a clear roadmap for sustainable design and construction.
Extended Release is an Off Script series to revisit conversations with our sources and explore new developments, gain deeper insights, and provide updates on the impact of their work.
75 حلقات
Manage episode 463765429 series 2941835
Join senior editor Andrea Corona and Nate Bolton, Engineering Design Manager at Genesis EIC, as they discuss the U.S. Department of Energy (DOE) new definition for zero emissions buildings (ZEB), offering a clear roadmap for sustainable design and construction.
Extended Release is an Off Script series to revisit conversations with our sources and explore new developments, gain deeper insights, and provide updates on the impact of their work.
75 حلقات
كل الحلقات
×![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 [Extended Release] Defining zero emissions buildings 10:47
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 FDA approves Opdivo subcutaneous version, Marinus Pharmaceuticals sells operations, Novo Nordisk pushes back against compounding pharmacies [The good, the bad, the ugly] 3:19
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 EU approves Novo-Catalent acquisition, CDMO National Resilience announces layoffs, FDA investigates blood cancer reports in gene therapy patients [The good, the bad, the ugly] 2:58
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 FDA approves Imkeldi oral solution, Alector axes workforce, Novartis announcnes layoffs [The good, the bad, the ugly] 3:12
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 FDA grants Regenxbio accelerated path for Duchenne, Neurogene reports death in Rett trial, Halozyme drops Evotec bid [The good, the bad, the ugly] 3:19
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 PTC secures FDA nod, Kronos Bio halts CDK9 development, Marinus slashes 45% of workforce amid setbacks [The good, the bad, the ugly] 3:13
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 Ascendis, Novo ink partnership, Court blocks Sun Pharma launch, FDA moves to delist phenylephrine [The good, the bad, the ugly] 3:35
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 MilliporeSigma expands ADC manufacturing, EU fines Teva, AZ exec under investigation in China [The good, the bad, the ugly] 2:57
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 [Extended Release] Antibiotic resistance crisis and the global efforts against superbugs 14:59
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 Nucleus RadioPharma expands production with new sites, FDA issues CRL to Camurus' hormone disorder drug, NHS rejects Eli Lilly's Alzheimer's drug over cost [The good, the bad, the ugly] 3:10
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 FDA approves AbbVie 24-hour Parkinson’s treatment, Sage Therapeutics axes workforce, FDA halts Novavax's COVID-flu vax trials [The good, the bad, the ugly] 2:50
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 Roche gets FDA nod for breast cancer combo, Kezar’s lupus drug trial on hold, Zealand Pharma’s hypoglycemia drug rejected over manufacturing [The good, the bad, the ugly] 2:58
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 Gilead inks deal with generics manufacturers to expand HIV drug access, J&J announces layoffs, Amgen sued for hiding $10.7B tax bill [The good, the bad, the ugly] 4:00
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 FDA approves BMS schizophrenia drug, bluebird bio announces layoffs, J&J talc subsidiary files for bankruptcy [The good, the bad, the ugly] 3:37
![Off Script: A Pharma Manufacturing Podcast podcast artwork](/static/images/64pixel.png)
1 [Extended Release] Schizophrenia treatment barriers, KarXT, and the future of neuroscience 17:28
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.